Your browser is no longer supported. Please, upgrade your browser.
TEVA Teva Pharmaceutical Industries Limited daily Stock Chart
Teva Pharmaceutical Industries Limited
Index- P/E- EPS (ttm)-5.87 Insider Own2.70% Shs Outstand917.03M Perf Week11.41%
Market Cap11.99B Forward P/E4.39 EPS next Y2.98 Insider Trans0.00% Shs Float912.43M Perf Month-12.21%
Income-5963.00M PEG- EPS next Q0.75 Inst Own55.80% Short Float7.44% Perf Quarter-23.10%
Sales23.42B P/S0.51 EPS this Y-96.10% Inst Trans-8.33% Short Ratio2.72 Perf Half Y-54.52%
Book/sh24.63 P/B0.53 EPS next Y-21.98% ROA-6.70% Target Price14.26 Perf Year-66.08%
Cash/sh0.77 P/C17.01 EPS next 5Y-9.11% ROE-21.80% 52W Range10.85 - 39.08 Perf YTD-63.92%
Dividend0.34 P/FCF4.94 EPS past 5Y-53.00% ROI1.10% 52W High-66.53% Beta0.54
Dividend %2.60% Quick Ratio0.70 Sales past 5Y3.60% Gross Margin49.80% 52W Low20.55% ATR0.75
Employees56960 Current Ratio1.00 Sales Q/Q0.80% Oper. Margin-19.70% RSI (14)47.34 Volatility6.60% 5.48%
OptionableYes Debt/Eq1.39 EPS Q/Q47.40% Profit Margin-25.50% Rel Volume0.95 Prev Close13.84
ShortableYes LT Debt/Eq1.28 EarningsNov 02 BMO Payout- Avg Volume25.02M Price13.08
Recom3.00 SMA202.17% SMA50-13.73% SMA200-49.52% Volume23,625,988 Change-5.49%
Nov-17-17Reiterated Mizuho Neutral $15 → $12
Nov-13-17Downgrade JP Morgan Neutral → Underweight
Nov-07-17Downgrade HSBC Securities Hold → Reduce
Nov-06-17Reiterated Susquehanna Positive $20 → $14
Nov-03-17Reiterated RBC Capital Mkts Underperform $13 → $8
Oct-30-17Reiterated RBC Capital Mkts Underperform $15 → $13
Sep-21-17Reiterated Bernstein Mkt Perform $28 → $20
Sep-18-17Reiterated RBC Capital Mkts Underperform $21 → $15
Sep-11-17Upgrade BTIG Research Neutral → Buy
Aug-24-17Downgrade Credit Suisse Neutral → Underperform
Aug-16-17Downgrade Citigroup Buy → Neutral
Aug-07-17Downgrade Morgan Stanley Equal-Weight → Underweight
Aug-04-17Downgrade RBC Capital Mkts Outperform → Underperform $37 → $21
Aug-04-17Downgrade Credit Suisse Outperform → Neutral
Aug-04-17Downgrade Bernstein Outperform → Mkt Perform
Aug-03-17Downgrade Oppenheimer Outperform → Perform
Jul-17-17Reiterated RBC Capital Mkts Outperform $38 → $37
Jun-16-17Upgrade Mizuho Neutral → Buy $25 → $30
Jun-16-17Initiated Cantor Fitzgerald Neutral $31
Feb-28-17Downgrade Argus Buy → Hold
Nov-20-17 04:30PM  Why Teva Pharmaceutical Industries, Snap, and NetEase Slumped Today Motley Fool -5.49%
Nov-17-17 01:45PM  John Paulson 13F: Exited Facebook, Took New Stakes In Q3 Investopedia +8.21%
01:03PM  ETFs with exposure to Teva Pharmaceutical Industries Ltd. : November 17, 2017 Capital Cube
09:13AM  Mizuho Wonders if Teva Can Avoid Downgrade to High Yield After Rocky 3Q Print SmarterAnalyst
07:31AM  Taking a Deeper Look at Antares Pharmas Financials in 2017 Market Realist
Nov-16-17 04:17PM  Teva Pharmaceutical Industries Limited (TEVA) Is Trading At A 48.87% Discount To Its Intrinsic Value Simply Wall St.
01:16PM  Billionaire Israel Izzy Englander Bets on Troubled Pharma Giants Teva and Valeant, Nixes Acadia SmarterAnalyst
09:02AM  Exploring Antares Pharmas Current Pipeline of Products Market Realist
07:30AM  Behind Novartiss Entresto and Gilenya Performances in 3Q17 Market Realist
03:05AM  Health and Happiness (H&H) Int'l. Hldgs. Ltd. -- Moody's: Health and Happiness' ratings unaffected by Swisse's buy-back of distribution rights Moody's
Nov-15-17 04:30PM  Why The Children's Place, Teva Pharmaceutical Industries, and Sears Holdings Jumped Today Motley Fool +7.23%
03:14PM  Will Teva's Pipeline Lead It to the Promised Land?
02:19PM  Teva Announces Prescription Copay Savings Program for Generic Gleevec® Tablets in the United States Business Wire
01:56PM  Despite Valeant Improvement, VRX Stock Price Is Still Too High InvestorPlace
01:28PM  GE among IQ100 leaders CNBC Videos
12:52PM  [$$] Foundation Consumer Healthcare Buys Plan B One-Step From Teva The Wall Street Journal
11:05AM  Cantor Continues to Play It Cautious on Teva Following Management Meeting SmarterAnalyst
09:01AM  Behind Novartiss Respiratory Drug Performance in 3Q17 Market Realist
Nov-14-17 01:05PM  Behind Sanofis 3Q17 Revenue Growth Market Realist
12:00PM  Oppenheimer Discouraged on Tevas Ability to Generate Gains in the Short-Term SmarterAnalyst
08:14AM  Triton (European Loan Conduit No. 26) PLC (ELoC 26) -- Moody's assigns B2 CFR to IWH UK Finco Limited Moody's
08:10AM  Todays Research Reports on Trending Tickers: Teva Pharmaceutical and Transocean ACCESSWIRE
Nov-13-17 03:37PM  Allergan to sell a quarter of its Teva stake in first quarter 2018 Reuters
12:48PM  For Teva Pharmaceuticals, No Recovery In Sight, Says Analyst Benzinga
11:48AM  Teva: It's Never Too Late to Sell
08:04AM  Teva's stock drops after J.P. Morgan downgrades to rare bearish rating MarketWatch
Nov-10-17 11:25AM  Short Sellers Back Way Off Major Pharma 24/7 Wall St.
09:49AM  Teva Pharmaceutical Industries Ltd. :TEVA-US: Earnings Analysis: Q3, 2017 By the Numbers : November 10, 2017 Capital Cube
07:00AM  No One is Coming to Save General Electric Company InvestorPlace
Nov-09-17 09:53AM  Teva Will Sink 50% After Fitch Downgrade: HSBC Investopedia
09:09AM  VIVUS (VVUS) Q3 Loss Narrows, Qsymia Falters, Shares Down Zacks
Nov-08-17 02:21PM  Teva Pharmaceutical Is Getting a Beating Between Analysts and Credit Rating Agencies Who See Valuation Heading Down the Drain SmarterAnalyst
02:00PM  Tevas stock and bonds walloped after Fitch downgrade to junk MarketWatch
Nov-07-17 01:41PM  Why Teva Pharma Could Fall Another 50% -5.80%
01:39PM  Wall Street Is All Mixed Up About Teva Pharmaceutical; Jami Rubin Cuts Price Target SmarterAnalyst
01:03PM  CBS leading the IQ100 index CNBC Videos
12:45PM  Teva Pharma: Junk Rating Adds to Woes
09:53AM  Teva's Stock Could Crash Another 50% After Debt Cut to Junk
09:10AM  Tuesdays Vital Data: Alibaba Group Holding Ltd (BABA), Teva Pharmaceutical Industries Ltd (ADR) (TEVA) and Valeant Pharmaceuticals Intl Inc (VRX) InvestorPlace
08:36AM  Teva Pharmaceuticals Ratings Cut at Fitch
08:10AM  Today's Research Reports on Stocks to Watch: Teva Pharmaceutical and TherapeuticsMD ACCESSWIRE
07:53AM  Tevas latest quarter was even worse than already-low expectations MarketWatch
07:38AM  Teva's stock, bonds fall after credit rating slashed to junk at Fitch MarketWatch
Nov-06-17 05:25PM  Teva Survives Price Cut As Billionaire Reportedly Mulls Stake Investor's Business Daily +8.86%
03:57PM  Tevas Credit Rating Cut to Junk by Fitch Bloomberg
02:27PM  Will Mylan Crush Teva's Generic Dreams?
12:33PM  ETFs with exposure to Teva Pharmaceutical Industries Ltd. : November 6, 2017 Capital Cube
12:19PM  [$$] A Rare Bright Spot for Mylan The Wall Street Journal
08:32AM  Pharma Stock Roundup: Pfizer, Teva's Q3 Earnings, Novartis Seeks New Indication for Kymriah Zacks
Nov-05-17 08:25AM  Billionaire Blavatnik weighs big share purchase in Teva Pharm - reports Reuters
06:13AM  Billionaire Blavatnik weighs big share purchase in Teva Pharm-reports Reuters
Nov-03-17 03:18PM  $675M sale of Plan B One-Step contraceptive complete American City Business Journals
01:19PM  IQ100 beating the market, up 28% CNBC Videos
01:18PM  Say It Ain't So: Teva Dividend Must Go?
01:02PM  Teva (TEVA) Stock Plunges 20% on Q3 Earnings Miss & View Cut Zacks
11:09AM  Analyst Eats 'Some Humble Pie,' Says Teva Needs To Deliver On Greater Visibility In Coming Months Benzinga
12:50AM  Teva's Misplaced Chinese Passion Bloomberg
Nov-02-17 10:47PM  Asia shares muted as investors assess Fed pick, US tax plan Associated Press -19.90%
08:46PM  The Single Biggest Reason Teva Pharmaceutical Industries Imploded and Fell 22% in October Motley Fool
05:27PM  Teva Dives On 'Long Road Ahead' After Earnings Miss, Guidance Cut Investor's Business Daily
04:04PM  Teva, General Electric Scoot into Thursdays 52-Week Low Club 24/7 Wall St.
03:12PM  Teva Pharmaceutical Industries Ltd -- Moody's says Teva's US generics business will face increased price pressure in 2018; a credit negative Moody's
02:35PM  Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Completes Plan B One-Step Asset Sale To Foundation Consumer Healthcare For $675M SmarterAnalyst
02:06PM  Why Teva Pharmaceutical Is Crashing Today Motley Fool
01:59PM  Teva shares topple on profit warning, uncertain future Reuters
01:48PM  Neurocrine Biosciences Exceeds Expectations With Ingrezza Launch Benzinga
01:26PM  Generic drugmakers, distributor shares slide after Teva reports worse pricing environment MarketWatch
01:15PM  Teva Announces Completion of Plan B One-Step® Divestiture to Foundation Consumer Healthcare Business Wire
12:36PM  Teva Pharmaceutical (TEVA) Stock Sinks on Lowered Outlook InvestorPlace
11:55AM  Teva Earnings Miss by Record Bloomberg
10:44AM  [$$] Teva Cuts Outlook Again in Perfect Storm of Problems The Wall Street Journal
10:41AM  Teva Stock Plunges on Earnings Results, but It's Still Not a Buy
10:40AM  [$$] Teva's Rebuild Is Going Nowhere The Wall Street Journal
10:07AM  Ouch! Teva Needs An IV, Stat
09:55AM  Teva Earnings Send Shares to New Low Not Seen in Over a Decade 24/7 Wall St.
08:36AM  Teva (TEVA) Q3 Earnings Miss, Cuts 2017 View, Stock Falls Zacks
08:10AM  Today's Research Reports on Stocks to Watch: Juno Therapeutics and Teva Pharmaceutical ACCESSWIRE
07:27AM  Teva falls short on Q3 profit, slashes 2017 estimates again Reuters
07:26AM  Teva Pharmaceutical Plunges After Slashing Its 2017 Forecast Bloomberg
07:21AM  Teva shares drop 8% on Q3 profit, revenue misses; lowered 2017 outlook MarketWatch
07:00AM  Teva Reports Third Quarter 2017 Financial Results Business Wire
05:30AM  Teva earnings: Facing down cheaper generic prices, generic competition of its own and a lot of debt MarketWatch
04:41AM  World's Largest Generic Drug Maker Seeks Tie Up With Producer of Chinese Viagra Bloomberg
Nov-01-17 06:49PM  Allergan to begin selling its 10 percent stake in Teva Reuters
05:46PM  Teva Pharmaceutical Industries Ltd (ADR) (TEVA) To Reduce Its Term Loan Debt With PARAGARD Asset Sale SmarterAnalyst
04:19PM  Teva Announces Completion of PARAGARD® Divestiture to CooperSurgical Business Wire
03:42PM  How Allergan plc Lost $4 Billion in Q3 and Still Performed Quite Well Motley Fool
11:47AM  Another Headache for Teva Shareholders The Wall Street Journal
Oct-31-17 05:27PM  Mylan Topples As President Named In 'Mind-Blowing' Antitrust Scheme Investor's Business Daily
01:04PM  Connecticut AG on drug pricing suit: Breadth of alleged c... CNBC Videos
10:14AM  Court Rules in Favor of Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Patent Infringement Suit on Uceris SmarterAnalyst
09:52AM  Teva Wins Generic Uceris® Patent Trial Business Wire
08:00AM  Today's Research Reports on Stocks to Watch: Halozyme Therapeutics and Teva Pharmaceuticals ACCESSWIRE
06:13AM  3 Retiree Stocks You'll Want to Buy Now Motley Fool
Oct-30-17 04:01PM  Kåre Schultz to Join Teva as President and Chief Executive Officer on November 1, 2017 Business Wire
11:31AM  Is a Turnaround in Store for Teva (TEVA) in Q3 Earnings? Zacks
Oct-29-17 10:30AM  Gilead Sciences, Inc. (GILD) Stock Isnt Worth It Here InvestorPlace
Oct-26-17 03:30PM  New Mexico sues pharma companies & drug distributors CNBC Videos
02:02PM  Do drugmakers stand to lose from opioid crackdown? CNBC Videos
08:36AM  Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Announces Abstracts at the ACAAI Annual Scientific Meeting SmarterAnalyst
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. It operates through two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. This segment also develops, manufactures, and sells active pharmaceutical ingredients. The Specialty Medicines segment provides branded specialty medicines for use in central nervous system and respiratory indications, as well as the women's health, oncology, and other specialty businesses. Its products in the central nervous system area comprise Copaxone for multiple sclerosis; Azilect for the treatment of Parkinson's disease; and Nuvigil for the treatment of excessive sleepiness associated with narcolepsy and certain other disorders. This segment's products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Qnasl, Braltus, Cinqair/Cinqaero, and Aerivio Spiromax for the treatment of asthma and chronic obstructive pulmonary disease, as well as Treanda/Bendeka, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. This segment also offers a portfolio of products in the women's health category, which includes ParaGard, Plan B One-Step, and OTC/Rx, as well as other products. The company has collaboration arrangements with Attenukine, Procter & Gamble Company, and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.